Lilly's Zepbound (tirzepatide) achieved total mean weight loss of 26.0% from baseline to 88 weeksDetailed results from SURMOUNT-4 have shown Zepbound (tirzepatide) injection achieved superior mean percent change in body weight...
Gastric pouch resizing for recurrent weight gain promotes weight stabilisation in well-selected patients4 days ago
COVID-19 pandemic: Bariatric surgery patients showed an increase in the percentage of weight regain4 days ago